Development of new nanoniosome carriers for vorinostat: Evaluation of anticancer efficacy in vitro

Vorinostat (VST) is a chemotherapeutic agent administrated for various types of cancers. However, it suffers from side effects and chemoresistance that reduce its application. Different nanoniosomes comprised Span 20, 60, 65 and 80 were prepared by the thin film hydration method and loaded with VST. The nanoniosomes were physicochemically characterized using particle size analysis and field emission scanning electron microscopy. The best formulation that was prepared using Span 65 (VST-NN-S65) included vesicle size of 127 nm with a narrow size distribution. VST-NN-S65 had an entrapment efficiency and loading capacity of 81.3±5.1 and 32.0±3.9%, respectively. Drug release rate measurements showed that 90% of VST was liberated within 1 h. Cytotoxicity assessments of VST-NN-S65 in HeLa and MCF7 cells indicated significant improvement in the effectiveness of VST, compared to the VST suspension. For VST-NN-S65, IC50 values of 26.3 and 6.6 μg mL^-1 were obtained for HeLa and MCF7 cell lines, respectively. In situ Apoptosis detection by the TUNEL assay revealed that Apoptosis mainly occurred in the cell lines.

Drug delivery; Niosome; SAHA; Suberoylanilide hydroxamic acid, Deacetylase inhibitor; Vesicle; Zolinza.